JP2001526888A - Method for separating short and long chain nucleic acids - Google Patents
Method for separating short and long chain nucleic acidsInfo
- Publication number
- JP2001526888A JP2001526888A JP2000525535A JP2000525535A JP2001526888A JP 2001526888 A JP2001526888 A JP 2001526888A JP 2000525535 A JP2000525535 A JP 2000525535A JP 2000525535 A JP2000525535 A JP 2000525535A JP 2001526888 A JP2001526888 A JP 2001526888A
- Authority
- JP
- Japan
- Prior art keywords
- membrane
- carrier
- nucleic acids
- carrier substance
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 30
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 30
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims abstract description 26
- 239000002245 particle Substances 0.000 claims abstract description 19
- 239000012528 membrane Substances 0.000 claims abstract description 18
- 239000000126 substance Substances 0.000 claims abstract description 16
- 239000007858 starting material Substances 0.000 claims abstract description 14
- 239000011148 porous material Substances 0.000 claims abstract description 10
- 238000000926 separation method Methods 0.000 claims abstract description 9
- 238000010828 elution Methods 0.000 claims abstract description 5
- 238000000746 purification Methods 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims abstract description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- 230000003196 chaotropic effect Effects 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000004677 Nylon Substances 0.000 claims description 4
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 4
- 229920001778 nylon Polymers 0.000 claims description 4
- 150000003377 silicon compounds Chemical class 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 235000012239 silicon dioxide Nutrition 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 239000006166 lysate Substances 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 229960000789 guanidine hydrochloride Drugs 0.000 claims description 2
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 claims description 2
- 229920002492 poly(sulfone) Polymers 0.000 claims description 2
- 239000012266 salt solution Substances 0.000 claims description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims description 2
- 235000009518 sodium iodide Nutrition 0.000 claims description 2
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 claims description 2
- 229910001488 sodium perchlorate Inorganic materials 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 210000003608 fece Anatomy 0.000 claims 1
- 239000011343 solid material Substances 0.000 claims 1
- 239000012876 carrier material Substances 0.000 abstract description 11
- 239000013612 plasmid Substances 0.000 description 16
- 238000005119 centrifugation Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 229940016590 sarkosyl Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Saccharide Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
(57)【要約】 本発明に係る方法は種々の出発物質からの短鎖及び長鎖核酸の分離と精製に関し、核酸を含む物質を溶解し、無機担体物質とともにインキュベーションし、担体物質の粒子サイズより大きい孔径を有する膜に塗布し、担体物質から溶出によって核酸を分離し、その際意外なことに担体物質は膜上に残ることを特徴とする。 (57) Abstract: The method according to the invention relates to the separation and purification of short and long chain nucleic acids from various starting materials, dissolving the nucleic acid containing material, incubating with an inorganic carrier material, the particle size of the carrier material. It is characterized in that it is applied to a membrane with a larger pore size and the nucleic acids are separated by elution from the carrier substance, whereby the carrier substance surprisingly remains on the membrane.
Description
【0001】 本発明は種々の生物学的その他の出発材料から大量の短鎖及び長鎖核酸を分離
及び精製するための簡単で極めて迅速な方法に関する。本方法は生物学、分子生
物学、司法、医学、分析及び生化学の分野で活動する多数の研究施設にとって重
要である。従って本発明の応用分野は法医学、医学診断、分子生物学、生化学、
遺伝子工学及びその他全てのの隣接分野である。The present invention relates to a simple and very fast method for separating and purifying large amounts of short and long nucleic acids from various biological and other starting materials. The method is important for many laboratories operating in the fields of biology, molecular biology, forensics, medicine, analysis and biochemistry. Therefore, the fields of application of the present invention are forensic medicine, medical diagnosis, molecular biology, biochemistry,
Genetic engineering and all other related fields.
【0002】 商業的に提供される全てのキットは種々のカオトロピック塩溶液の存在で無機
担体に核酸を結合するというよく知られた原理に基づいており、担体物質として
細かく粉砕したガラス粉末(例えばGlasmilk, BIO 101, La Jolla, CA)、ケイ ソウ土(Sigma社)又はシリカゲル(Diagen、ドイツ国特許第4139664号A1)を使用
する。All commercially available kits are based on the well-known principle of binding nucleic acids to inorganic carriers in the presence of various chaotropic salt solutions, and use finely ground glass powder (eg Glassmilk) as carrier material. BIO 101, La Jolla, CA), diatomaceous earth (Sigma) or silica gel (Diagen, DE 4139664 A1).
【0003】 多数の様々な用途にとって実用的な核酸分離法が米国特許第5,234,809号明細 書(Boom)に示されている。そこでは出発材料をカオトロピック緩衝液及びDNAを 結合した固相とともにインキュベーションすることによって核酸を含む出発材料
から核酸を分離する方法が記載されている。カオトロピック緩衝液は出発材料の
溶解と固相への核酸の結合を実現する。この方法は、少量の試料から核酸を分離
するのに好適であり、特にウイルス核酸の分離の分野で実際に応用される。A practical method for separating nucleic acids for a number of different applications is shown in US Pat. No. 5,234,809 (Boom). It describes a method for separating nucleic acids from starting materials containing nucleic acids by incubating the starting materials with a chaotropic buffer and a solid phase bound to DNA. The chaotropic buffer allows dissolution of the starting material and binding of the nucleic acid to the solid phase. This method is suitable for separating nucleic acids from a small amount of sample, and has practical application particularly in the field of viral nucleic acid separation.
【0004】 本発明の課題は、とりわけ種々の出発材料から核酸、特にプラスミドDNAを分 離し、その後の適用の高い品質パラメータに対応する分離核酸をもたらす、実施
が極めて簡単で迅速かつ安価な方法を開発することである。The object of the present invention is, inter alia, to provide a method which is very simple, fast and inexpensive to separate nucleic acids, in particular plasmid DNA, from a variety of starting materials and subsequently to obtain separated nucleic acids corresponding to high quality parameters of application. It is to develop.
【0005】 この課題は特許請求の範囲により、即ち本発明に基づき無機担体物質への結合
をバッチ法で行い、結合された核酸を次にクロマトグラフィーで処理することに
より複合バッチ・カラム法によって実現される。This object is achieved according to the claims, ie according to the invention, by means of a combined batch column method, in which the binding to the inorganic carrier substance is carried out in a batch process and the bound nucleic acids are subsequently chromatographed. Is done.
【0006】 種々の生物学的及びその他の出発材料から短鎖及び長鎖核酸を分離し精製する
ための本発明に係る方法は、 −核酸を含む材料の溶解、 −無機担体物質とのインキュベーション、 −担体物質の粒子サイズより大きい孔径を有する膜への塗布、 −担体粒子は膜上に残る、溶出による担体物質からの核酸の分離、 を特徴とする。The method according to the invention for separating and purifying short and long nucleic acids from various biological and other starting materials comprises: dissolving the material containing the nucleic acids, incubation with inorganic carrier substances, -Application to a membrane having a pore size larger than the particle size of the carrier substance,-separation of the nucleic acid from the carrier substance by elution, the carrier particles remaining on the membrane.
【0007】 核酸を含む好適な出発材料として複合生物学的系、例えば場合によっては固体
物質に結合された血液、組織、尿又は糞便試料が考えられる。しかし本発明に係
る方法は、他の出発材料例えば細菌ライゼート、植物性成分からの短鎖及び長鎖
核酸、或いはPCR付加物又はアガロースゲルからのDNA断片の分離と精製にも適し
ている。[0007] Suitable starting materials containing nucleic acids include complex biological systems, such as blood, tissue, urine or stool samples, optionally bound to solid substances. However, the method according to the invention is also suitable for the separation and purification of other starting materials such as bacterial lysates, short and long nucleic acids from plant components, or PCR adducts or DNA fragments from agarose gels.
【0008】 好適な担体物質は、ケイ素化合物例えば二酸化ケイ素、ケイ酸又はシリカゲル
である。本発明に基づき使用されるケイ素化合物は7nmないし5000nm、好ましく は7-40nm又は500-500nmの平均粒子サイズを有する。[0008] Suitable carrier materials are silicon compounds such as silicon dioxide, silicic acid or silica gel. The silicon compounds used according to the invention have an average particle size of 7 nm to 5000 nm, preferably 7-40 nm or 500-500 nm.
【0009】 出発物質の溶解に続く担体物質とのインキュベーションは、カオトロピック塩
を有する緩衝系の中で行われる。カオトロピック塩は好ましくは濃度1ないし10M
の例えばイソチオシアン酸グアニジン、塩酸グアニジン、塩化リチウム、過塩素
酸ナトリウム、ヨウ化ナトリウム及び/又は尿素である。[0009] Incubation with the carrier material following the dissolution of the starting material is performed in a buffer system with chaotropic salts. The chaotropic salt is preferably at a concentration of 1 to 10 M
For example, guanidine isothiocyanate, guanidine hydrochloride, lithium chloride, sodium perchlorate, sodium iodide and / or urea.
【0010】 溶解を促進する成分として洗剤、例えばTritonX-100、Tween、N-ラウリルサル
コシル、SDS及び/又はCTAB、場合によってはタンパク質分解酵素例えばプロテ イナーゼを使用する。[0010] Detergents such as Triton X-100, Tween, N-lauryl sarkosyl, SDS and / or CTAB, and optionally proteolytic enzymes such as proteinases are used as components which promote dissolution.
【0011】 本発明によれば使用する無機担体物質の分離のために、使用される担体物質の
粒子サイズより大きな孔径を有する膜を、好ましくは遠心分離カートリッジで使
用することが好ましい。その場合使用される担体材料の平均粒子サイズに応じて
膜の孔径を確定する。本発明に基づきナイロン又はポリスルホン膜を使用するこ
とが好ましい。According to the invention, for the separation of the inorganic carrier substance used, it is preferred to use a membrane having a pore size larger than the particle size of the carrier substance used, preferably in a centrifuge cartridge. In that case, the pore size of the membrane is determined according to the average particle size of the carrier material used. It is preferred to use a nylon or polysulfone membrane according to the invention.
【0012】 核酸が固定された担体を膜への塗布の前又は後に洗浄する。続いて担体からの
核酸の溶出は、当業者に明らかなように低いイオン強度の緩衝液によって行われ
る。The carrier on which the nucleic acid is immobilized is washed before or after application to the membrane. Subsequently, elution of the nucleic acid from the carrier is performed with a low ionic strength buffer, as will be clear to the skilled person.
【0013】 核酸の精製のために有効に利用できる遠心分離膜は、使用される担体物質の粒
子サイズより小さな孔径をもたねばならないことは一般に自明なことである。遠
心分離膜の細孔より小さな粒径を有する無機粒子は、遠心分離段階の間に常に細
孔によって遠心されるからである。[0013] It is generally self-evident that centrifugal membranes that can be effectively used for the purification of nucleic acids must have a pore size smaller than the particle size of the carrier material used. This is because inorganic particles having a smaller particle size than the pores of the centrifuge membrane are always centrifuged by the pores during the centrifugation step.
【0014】 本発明は、商業的に提供される遠心分離カラムの孔径よりはるかに小さな無機
担体粒子を組み入れた複合バッチ・カラム式核酸分離法が可能であるという意外 な確認に基づいている。[0014] The present invention is based on the surprising confirmation that a combined batch column nucleic acid separation method incorporating inorganic carrier particles much smaller than the pore size of commercially available centrifugation columns is possible.
【0015】 意外なことにこのような複合法は50nm以下の無機担体物質でも実現できるから
、このような粒子の極めて大きな結合面の利点を利用することができる。[0015] Surprisingly, such a composite method can also be realized with an inorganic carrier substance of 50 nm or less, so that the advantage of an extremely large binding surface of such particles can be exploited.
【0016】 バッチ法とカラム法の組合せという本発明に係る方法は任意の担体物質、従っ
て微小な無機担体粒子とその極めて大きな比表面積も利用するので、出発物質の
容積に関して無制限である。The process according to the invention, which is a combination of a batch process and a column process, is unlimited with respect to the volume of the starting material, since it utilizes any carrier material, and thus also small inorganic carrier particles and their very large specific surface area.
【0017】 このことは、使用する担体物質へのプラスミドDNAの結合段階をカラムの中で 行わないでもよいので、従来ならば出発材料(例えば細菌ライゼート)の量に応じ
て増加しなければならない必要な原液にもはや制限がないことを意味する。This means that the step of binding the plasmid DNA to the carrier material used does not have to be carried out in the column, so that conventionally it has to be increased according to the amount of starting material (eg bacterial lysate). Means that there is no longer any restriction on the stock solution.
【0018】 本方法は高純度のDNAのすこぶる高い収量をもたらし、しかも実施が極めて簡 単であり、例えばプラスミドDNAの分離の場合、広く普及している陰イオン交換 体系と比較してはるかに短時間で実現することができる。The method results in very high yields of highly pure DNA and is extremely simple to carry out, for example in the case of plasmid DNA separation, which is much shorter than the widely used anion exchange system. Can be realized in time.
【0019】 次に実施例に基づき本発明を示す。Next, the present invention will be described based on examples.
【0020】 1. プラスミドDNAの微量分離 2mlの細菌夜間培養液を2ml Eppendorf反応容器に移し、12,000rpmで1分間遠心
分離する。続いて細胞ペレットを100μlの溶液I(トリスHCL、EDTA;グルコース
)で再懸濁する。300μlの溶液II(NaOH;SDS)を加え、反応容器を短時間注意深 く振ることによって細胞を溶解する。300μlの溶液III(酢酸ナトリウム;塩酸 グアニジニウム)を加えることによって必要な中和反応を行う。次に14,000rpm で5分間の遠心分離段階により染色体DNAとタンパク質を沈殿させ、透明に遠心し
た上澄みを次にシリカナノ粒子(平均粒子サイズ40nm)からなる無機担体の20μ
lの懸濁液とともにインキュベートする。続いて液を小型遠心分離カラム(例え ばMicro Spin Nylon 又はMicro Spin PSE; LIDA社)へ移す。プラスミドDNAが結
合された担体粒子を12,000rpmで1分の遠心分離により濾膜の表面に移し、そこで
洗浄液(60%エタノール;NaCl)の添加と再度の遠心分離段階により洗浄する。
洗浄段階をもう一度繰り返す。最後に12,000rpmで2分間の遠心分離により残りの
エタノールを担体物質から除去する。100μlの低塩緩衝液(例えば10mMのトリス
HCl)を70℃で加え、次に12,000rpmで1分間遠心分離することによって、結合し たプラスミドDNAを剥離する。遠心分離液は分離されたプラスミドDNAを含む。1. Microseparation of plasmid DNA Transfer 2 ml of bacterial overnight culture to a 2 ml Eppendorf reaction vessel and centrifuge at 12,000 rpm for 1 minute. Subsequently, the cell pellet is resuspended with 100 μl of solution I (Tris HCL, EDTA; glucose). Add 300 μl of Solution II (NaOH; SDS) and lyse the cells by briefly and carefully shaking the reaction vessel. The required neutralization reaction is performed by adding 300 μl of solution III (sodium acetate; guanidinium hydrochloride). Next, the chromosomal DNA and proteins are precipitated by a centrifugation step at 14,000 rpm for 5 minutes, and the supernatant obtained by centrifugation is then centrifuged to 20 μl of an inorganic carrier composed of silica nanoparticles (average particle size 40 nm).
Incubate with 1 suspension. Subsequently, the solution is transferred to a small centrifugation column (for example, Micro Spin Nylon or Micro Spin PSE; LIDA). The carrier particles to which the plasmid DNA is bound are transferred to the surface of the filter membrane by centrifugation at 12,000 rpm for 1 minute, whereupon they are washed by adding a washing solution (60% ethanol; NaCl) and another centrifugation step.
Repeat the washing step once more. Finally, residual ethanol is removed from the carrier material by centrifugation at 12,000 rpm for 2 minutes. 100 μl low salt buffer (eg 10 mM Tris
HCl) at 70 ° C and then centrifuged at 12,000 rpm for 1 minute to detach the bound plasmid DNA. The centrifuge contains the separated plasmid DNA.
【0021】 個々の細胞コロニーの分離されたプラスミドDNA(微量)のゲル電気泳動図を図1
に示す。FIG. 1 shows a gel electrophoresis diagram of isolated plasmid DNA (trace) of individual cell colonies.
Shown in
【0022】 2. プラスミドDNAの中量分離 25mlの細菌夜間培養を50ml Flacon反応容器に移し、5,000rpmで10分間遠心分 離する。続いて細胞ペレットを1mlの溶液I(トリスHCL、EDTA;グルコース)で 再懸濁する。1,8mlの溶液II(NaOH;SDS)を加え、反応容器を短時間注意深く振り
、5分間インキュベーションすることによって細胞を溶解する。1,8mlの溶液III (酢酸ナトリウム;塩酸グアニジニウム)を加え、次に氷温で10分インユベーシ
ョンすることによって必要な中和反応を行う。次に5,000rpmで10 分間の遠心分 離段階により染色体DNAとタンパク質を沈殿させ、透明に遠心した上澄みを次に シリカナノ粒子(平均粒度40nm)からなる無機担体の150μlの懸濁液とともにイ
ンキュベーションする。続いて液を遠心カラム(例えばMicro Spin Nylon; LIDA
社)へ移す。プラスミドDNAが結合された担体粒子を5,000rpmで5分の遠心分離に
より濾膜の表面に移し、そこで洗浄液(60%エタノール;NaCl)の添加と再度の
遠心分離段階により洗浄する。洗浄段階をもう一度繰り返す。最後に5,000rpmで
10分の遠心分離又は遠心分離カラムの37℃で10分のインキュベーションにより残
りのエタノールを担体物質から除去する。200μl−300μlの低塩緩衝液(例えば
10mMのトリスHCl)を70℃で加え、次に5,000rpmで5分間遠心分離することによっ
て、結合したプラスミドDNAが剥離する。遠心分離液は分離されたプラスミドDNA
を含む。2. Medium volume isolation of plasmid DNA Transfer 25 ml of bacterial overnight culture to a 50 ml Flacon reaction vessel and centrifuge at 5,000 rpm for 10 minutes. Subsequently, the cell pellet is resuspended with 1 ml of solution I (Tris HCL, EDTA; glucose). Add 1.8 ml of Solution II (NaOH; SDS), lyse the cells by carefully shaking the reaction vessel briefly and incubating for 5 minutes. The required neutralization reaction is carried out by adding 1.8 ml of solution III (sodium acetate; guanidinium hydrochloride) and then incubating at ice temperature for 10 minutes. The chromosomal DNA and proteins are then precipitated by a centrifugation step at 5,000 rpm for 10 minutes, and the supernatant, which has been centrifuged transparently, is then incubated with a 150 μl suspension of an inorganic carrier consisting of silica nanoparticles (average particle size 40 nm). Subsequently, the solution is centrifuged (for example, Micro Spin Nylon; LIDA).
Company). The carrier particles to which the plasmid DNA is bound are transferred to the surface of the filter membrane by centrifugation at 5,000 rpm for 5 minutes, whereupon they are washed by adding a washing solution (60% ethanol; NaCl) and centrifuging again. Repeat the washing step once more. Finally at 5,000 rpm
The residual ethanol is removed from the carrier material by centrifugation for 10 minutes or incubation of the centrifugation column for 10 minutes at 37 ° C. 200 μl-300 μl of low salt buffer (eg,
Bound plasmid DNA is detached by adding 10 mM Tris-HCl) at 70 ° C and then centrifuging at 5,000 rpm for 5 minutes. The centrifuge is the separated plasmid DNA
including.
【0023】 個々の個別細胞コロニーの分離されたプラスミドDNA(中量)のゲル電気泳動図 を図2に示す。FIG. 2 shows a gel electrophoresis diagram of the isolated plasmid DNA (medium amount) of each individual cell colony.
【0024】 3.本発明方法と、商業的に使用される、陰イオン交換体をベースとしたプラス
ミドDNA(中量)分離システムとの必要な操作段階及び所要時間消費の比較[0024] 3. Comparison of required operating steps and time consumption between the method of the present invention and a commercially used anion exchanger-based plasmid DNA (medium) separation system
【表1】 [Table 1]
【図1】 分離されたプラスミドDNA(微量)のゲル電気泳動図である。FIG. 1 is a gel electrophoresis diagram of a separated plasmid DNA (trace amount).
【図2】 分離されたプラスミドDNA(中量)のゲル電気泳動図である。FIG. 2 is a gel electrophoresis diagram of the separated plasmid DNA (medium amount).
───────────────────────────────────────────────────── フロントページの続き (81)指定国 EP(AT,BE,CH,CY, DE,DK,ES,FI,FR,GB,GR,IE,I T,LU,MC,NL,PT,SE),OA(BF,BJ ,CF,CG,CI,CM,GA,GN,GW,ML, MR,NE,SN,TD,TG),AP(GH,GM,K E,LS,MW,SD,SZ,UG,ZW),EA(AM ,AZ,BY,KG,KZ,MD,RU,TJ,TM) ,AL,AM,AT,AU,AZ,BA,BB,BG, BR,BY,CA,CH,CN,CU,CZ,DK,E E,ES,FI,GB,GE,GH,GM,HR,HU ,ID,IL,IS,JP,KE,KG,KP,KR, KZ,LC,LK,LR,LS,LT,LU,LV,M D,MG,MK,MN,MW,MX,NO,NZ,PL ,PT,RO,RU,SD,SE,SG,SI,SK, SL,TJ,TM,TR,TT,UA,UG,US,U Z,VN,YU,ZW──────────────────────────────────────────────────続 き Continuation of front page (81) Designated country EP (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE ), OA (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG), AP (GH, GM, KE, LS, MW, SD, SZ, UG, ZW), EA (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DK, EE, ES, FI, GB, GE, GH, GM, HR, HU, ID, IL, IS, JP, KE, KG, KP, KR , KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
Claims (11)
分離及び精製のための方法。1. dissolution of a material containing nucleic acids;-incubation with an inorganic carrier substance;-application to a membrane having a pore size larger than the particle size of the carrier substance;-carrier particles remaining on the membrane, elution of the carrier substance. For the separation and purification of short and long nucleic acids from various biological and other starting materials.
物若しくは寒天ゲルからのDNA断片であることを特徴とする請求項1に記載の方法
。2. The starting material is a complex biological system, such as blood, tissue, urine or feces, bacterial lysate, plant components or PCR adducts or DNA fragments from agar gel, optionally combined with solid material. The method of claim 1, wherein:
リカゲルを使用することを特徴とする請求項1又は2に記載の方法。3. The process as claimed in claim 1, wherein a silicon compound such as silicon dioxide, silicic acid or silica gel is used as the carrier substance.
し40nm又は500ないし5000nmの平均粒子サイズを有することを特徴とする請求項 1ないし3のいずれか1つに記載の方法。4. The process according to claim 1, wherein the silicon compound used has an average particle size of 7 nn to 5000 nm, preferably 7 to 40 nm or 500 to 5000 nm.
溶解成分の組合せによって行われることを特徴とする請求項1ないし4のいずれ
か1つに記載の方法。5. The method according to claim 1, wherein the dissolution of the nucleic acid and the binding to the inorganic carrier substance are carried out by a combination of a chaotropic salt solution and a dissolved component.
素を使用することを特徴とする請求項5に記載の方法。6. The method according to claim 5, wherein guanidine isothiocyanate, guanidine hydrochloride, lithium chloride, sodium perchlorate, sodium iodide and / or urea are used as the chaotropic salt.
ことを特徴とする請求項5又は6に記載の方法。7. The method according to claim 5, wherein a detergent and / or a protease is used as the dissolving component.
する請求項1ないし7のいずれか1つに記載の方法。8. The method according to claim 1, wherein a nylon or polysulfone membrane is used as the membrane.
とを特徴とする請求項1ないし8のいずれか1つに記載の方法。9. The method according to claim 1, wherein the pore size of the membrane is determined according to the particle size of the carrier substance used.
とを特徴とする請求項1ないし9のいずれか1つに記載の方法。10. The method according to claim 1, wherein the nucleic acid on which the carrier is immobilized is washed before or after the nucleic acid is applied to the membrane.
うことを特徴とする請求項1ないし10のいずれか1つに記載の方法。11. The method according to claim 1, wherein the elution of the nucleic acid from the carrier is performed using a buffer having a low ionic strength.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19758102.1 | 1997-12-18 | ||
DE19758102 | 1997-12-18 | ||
PCT/DE1998/003728 WO1999032616A2 (en) | 1997-12-18 | 1998-12-18 | Method for isolating short and long-chain nucleic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001526888A true JP2001526888A (en) | 2001-12-25 |
Family
ID=7853518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000525535A Pending JP2001526888A (en) | 1997-12-18 | 1998-12-18 | Method for separating short and long chain nucleic acids |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1037973A2 (en) |
JP (1) | JP2001526888A (en) |
AU (1) | AU2509799A (en) |
CA (1) | CA2315257A1 (en) |
DE (1) | DE19858447A1 (en) |
WO (1) | WO1999032616A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006523463A (en) * | 2003-04-16 | 2006-10-19 | ジェントラ システムズ インコーポレイテッド | Compositions and methods for purifying RNA using a solid support |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10222133A1 (en) * | 2002-05-17 | 2003-12-04 | Gl Biotech Gmbh | Process for nucleic acid extraction and nucleic acid purification |
US7482116B2 (en) | 2002-06-07 | 2009-01-27 | Dna Genotek Inc. | Compositions and methods for obtaining nucleic acids from sputum |
DE102008057317A1 (en) | 2007-11-13 | 2009-09-10 | Stratec Biomedical Systems Ag | Device and method for the purification of biomolecules |
KR101569832B1 (en) * | 2008-11-19 | 2015-11-18 | 삼성전자주식회사 | A method for separating genomic DNA and plasmid DNA from each other in a sample, and a kit therefor |
CN106442039B (en) | 2011-06-19 | 2020-08-07 | 阿博根公司 | Devices, solutions and methods for sample collection |
PT3114225T (en) | 2014-03-07 | 2021-07-26 | Dna Genotek Inc | Composition and method for stabilizing nucleic acids in biological samples |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075430A (en) * | 1988-12-12 | 1991-12-24 | Bio-Rad Laboratories, Inc. | Process for the purification of DNA on diatomaceous earth |
NL8900725A (en) * | 1989-03-23 | 1990-10-16 | Az Univ Amsterdam | METHOD AND COMBINATION OF AGENTS FOR INSULATING NUCLEIC ACID. |
US5155018A (en) * | 1991-07-10 | 1992-10-13 | Hahnemann University | Process and kit for isolating and purifying RNA from biological sources |
AU689815B2 (en) * | 1993-08-30 | 1998-04-09 | Promega Corporation | Nucleic acid purification compositions and methods |
DE4422040A1 (en) * | 1994-06-14 | 1995-12-21 | Invitek Gmbh | Isolation and purificn. of PCR prods. |
DE4422044A1 (en) * | 1994-06-14 | 1995-12-21 | Invitek Gmbh | Simple isolation and purificn. of nucleic acid from various samples |
ATE184013T1 (en) * | 1994-06-14 | 1999-09-15 | Invitek Gmbh | UNIVERSAL PROCESS FOR ISOLATION AND PURIFICATION OF NUCLEIC ACIDS FROM EXTREMELY SMALL QUANTITIES AS WELL AS VERY HIGHLY CONTAMINATED VARIOUS STARTING MATERIALS |
DE19506887C2 (en) * | 1995-02-17 | 1999-10-14 | Invitek Gmbh | Process for the simultaneous isolation of genomic DNA and high-purity total RNA |
US5783686A (en) * | 1995-09-15 | 1998-07-21 | Beckman Instruments, Inc. | Method for purifying nucleic acids from heterogenous mixtures |
DE19717717B4 (en) * | 1997-04-18 | 2007-08-02 | InViTek Gesellschaft für Biotechnik & Biodesign mbH | Method for the non-invasive detection of malignant tumors of the lung |
-
1998
- 1998-12-18 EP EP98966787A patent/EP1037973A2/en not_active Withdrawn
- 1998-12-18 DE DE19858447A patent/DE19858447A1/en not_active Withdrawn
- 1998-12-18 JP JP2000525535A patent/JP2001526888A/en active Pending
- 1998-12-18 WO PCT/DE1998/003728 patent/WO1999032616A2/en not_active Application Discontinuation
- 1998-12-18 AU AU25097/99A patent/AU2509799A/en not_active Abandoned
- 1998-12-18 CA CA002315257A patent/CA2315257A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006523463A (en) * | 2003-04-16 | 2006-10-19 | ジェントラ システムズ インコーポレイテッド | Compositions and methods for purifying RNA using a solid support |
JP2010263919A (en) * | 2003-04-16 | 2010-11-25 | Qiagen North American Holdings Inc | Composition and method for using solid support to purify rna |
Also Published As
Publication number | Publication date |
---|---|
DE19858447A1 (en) | 1999-07-01 |
CA2315257A1 (en) | 1999-07-01 |
WO1999032616A3 (en) | 1999-09-10 |
EP1037973A2 (en) | 2000-09-27 |
AU2509799A (en) | 1999-07-12 |
WO1999032616A2 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5972613A (en) | Methods of nucleic acid isolation | |
JP3761573B2 (en) | A general method for the isolation and purification of nucleic acids from a very wide variety of starting materials that are extremely small and very strongly contaminated | |
EP0988307B1 (en) | Solid-phase nucleic acid isolation | |
JP4369619B2 (en) | Rapid and simple isolation method for circular nucleic acids | |
RU2241004C2 (en) | Composition and method for isolation of nucleic acids from complex material using anti-chaotropic salt | |
JP5390772B2 (en) | Compositions and methods for purifying nucleic acids from stabilizing reagents | |
US6969603B2 (en) | Method for isolating DNA | |
US7888006B2 (en) | Method for isolating DNA from biological samples | |
US20080300397A1 (en) | Modified spin column for simple and rapid plasmid dna extraction | |
JP2002502856A (en) | Methods for isolating and purifying nucleic acids | |
JPH07501223A (en) | Apparatus and method for isolating nucleic acids | |
CN111448315B (en) | Method for separating DNA by Cas protein system | |
US20090306359A1 (en) | Non-alcoholic buffer formulations for isolating, purifying and recovering long-chain and short-chain nucleic acids | |
US20090130687A1 (en) | Formulations and method isolating nucleic acids from arbitrary complex starting materials and subsequent complex genetic materials | |
JP2001526888A (en) | Method for separating short and long chain nucleic acids | |
JP2023527475A (en) | Nucleic acid extraction method and use | |
EP2060629B1 (en) | Method of separating small RNA molecules using kosmotropic salt | |
JP5230196B2 (en) | Instruments and methods for more efficient isolation of nucleic acids | |
US6855816B1 (en) | Method for producing endotoxin-free nucleic acids and the use thereof | |
EP3344643B1 (en) | Methods for co-isolation of nucleic acids and proteins | |
RU2116795C1 (en) | Set for dna isolation | |
JP3811767B2 (en) | Method for purifying nucleic acids from a homogeneous mixture | |
JP3811767B6 (en) | Method for purifying nucleic acids from a homogeneous mixture | |
SU1161550A1 (en) | Method of obtaining nuclease s1 |